Julia Karbach

8.9k total citations · 3 hit papers
97 papers, 6.1k citations indexed

About

Julia Karbach is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Julia Karbach has authored 97 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Immunology, 37 papers in Molecular Biology and 28 papers in Oncology. Recurrent topics in Julia Karbach's work include Immunotherapy and Immune Responses (62 papers), T-cell and B-cell Immunology (31 papers) and vaccines and immunoinformatics approaches (22 papers). Julia Karbach is often cited by papers focused on Immunotherapy and Immune Responses (62 papers), T-cell and B-cell Immunology (31 papers) and vaccines and immunoinformatics approaches (22 papers). Julia Karbach collaborates with scholars based in Germany, United States and Switzerland. Julia Karbach's co-authors include Elke Jäger, Alexander Knuth, Michael Arand, Lloyd J. Old, Elisabeth Stockert, Mark Ringhoffer, Yao‐Tseng Chen, Dirk Jäger, Gerd Ritter and Sacha Gnjatic and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Julia Karbach

90 papers receiving 6.0k citations

Hit Papers

Simultaneous Humoral and Cellular Immune Response against... 1998 2026 2007 2016 1998 1998 2013 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes
    1998 594 citations Elke Jäger, Julia Karbach et al. profile →
  2. A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens
    1998 593 citations Elisabeth Stockert, Elke Jäger et al. profile →
  3. Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
    2013 505 citations Julia Karbach, Elke Jäger et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Karbach Germany 36 4.8k 2.6k 2.4k 788 366 97 6.1k
Bernard Lethé Belgium 28 5.0k 1.0× 3.1k 1.2× 2.1k 0.9× 465 0.6× 466 1.3× 39 6.0k
Timothy M. Clay United States 41 3.2k 0.7× 2.6k 1.0× 2.2k 0.9× 491 0.6× 796 2.2× 97 5.9k
Thorbald van Hall Netherlands 47 6.1k 1.3× 2.5k 1.0× 4.1k 1.7× 546 0.7× 480 1.3× 127 8.1k
Christophe Lurquin Belgium 32 7.3k 1.5× 4.7k 1.8× 3.3k 1.4× 764 1.0× 785 2.1× 45 8.9k
Carlo Heirman Belgium 47 4.8k 1.0× 3.2k 1.2× 2.2k 0.9× 382 0.5× 933 2.5× 118 6.7k
Roberto S. Accolla Italy 41 3.9k 0.8× 1.4k 0.5× 1.2k 0.5× 1.4k 1.8× 421 1.2× 179 5.8k
Maria R. Parkhurst United States 37 7.1k 1.5× 3.1k 1.2× 6.0k 2.5× 772 1.0× 1.1k 3.0× 64 9.2k
Sebastian Kreiter Germany 29 2.9k 0.6× 2.6k 1.0× 1.9k 0.8× 340 0.4× 661 1.8× 64 4.6k
Jill E. Slansky United States 37 4.0k 0.8× 2.0k 0.8× 2.5k 1.0× 224 0.3× 610 1.7× 79 6.4k
Amy Hobeika United States 34 2.5k 0.5× 2.0k 0.8× 1.7k 0.7× 296 0.4× 318 0.9× 90 4.2k

Countries citing papers authored by Julia Karbach

Since Specialization
Citations

This map shows the geographic impact of Julia Karbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Karbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Karbach more than expected).

Fields of papers citing papers by Julia Karbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Karbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Karbach. The network helps show where Julia Karbach may publish in the future.

Co-authorship network of co-authors of Julia Karbach

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Karbach. A scholar is included among the top collaborators of Julia Karbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Karbach. Julia Karbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Kloor, Matthias, Miriam Reuschenbach, Claudia Pauligk, et al.. (2020). A Frameshift Peptide Neoantigen-Based Vaccine for Mismatch Repair-Deficient Cancers: A Phase I/IIa Clinical Trial. Clinical Cancer Research. 26(17). 4503–4510. 92 indexed citations
5.
Hendrix, Philipp, et al.. (2017). Cognitive function surrounding resection of nonfunctioning pituitary adenomas with suprasellar extension: A prospective matched-control study. Journal of Clinical Neuroscience. 40. 109–114. 21 indexed citations
6.
Schmidt, Julien, Philippe Guillaume, Danijel Dojcinovic, et al.. (2017). In silico and cell-based analyses reveal strong divergence between prediction and observation of T-cell–recognized tumor antigen T-cell epitopes. Journal of Biological Chemistry. 292(28). 11840–11849. 23 indexed citations
7.
Karbach, Julia, Sacha Gnjatic, Akin Atmaca, et al.. (2014). Long-term Complete Remission Following Radiosurgery and Immunotherapy in a Melanoma Patient with Brain Metastasis: Immunologic Correlates. Cancer Immunology Research. 2(5). 404–409. 12 indexed citations
8.
Karbach, Julia, Antje Neumann, Kathrin Brand, et al.. (2012). Phase I Clinical Trial of Mixed Bacterial Vaccine (Coley's Toxins) in Patients with NY-ESO-1 Expressing Cancers: Immunological Effects and Clinical Activity. Clinical Cancer Research. 18(19). 5449–5459. 79 indexed citations
9.
Karbach, Julia, Antje Neumann, Claudia Wahle, et al.. (2012). Therapeutic Administration of a Synthetic CpG Oligodeoxynucleotide Triggers Formation of Anti-CpG Antibodies. Cancer Research. 72(17). 4304–4310. 18 indexed citations
10.
Karbach, Julia, Antje Neumann, Akin Atmaca, et al.. (2010). Efficient In vivo Priming by Vaccination with Recombinant NY-ESO-1 Protein and CpG in Antigen Naïve Prostate Cancer Patients. Clinical Cancer Research. 17(4). 861–870. 63 indexed citations
11.
Neumann, Antje, Julia Karbach, Akin Atmaca, & Elke Jäger. (2010). Langzeitremission bei malignem Melanom Stadium IV nach antigenspezifischer Immuntherapie. Medizinische Klinik. 105(4). 273–275.
12.
Beyer, Marc, Julia Karbach, Michael R. Mallmann, et al.. (2009). Cancer Vaccine Enhanced, Non–Tumor-Reactive CD8+ T Cells Exhibit a Distinct Molecular Program Associated with “Division Arrest Anergy”. Cancer Research. 69(10). 4346–4354. 12 indexed citations
13.
Shebzukhov, Yuriy V., Inna N. Lavrik, Julia Karbach, et al.. (2007). Human tankyrases are aberrantly expressed in colon tumors and contain multiple epitopes that induce humoral and cellular immune responses in cancer patients. Cancer Immunology Immunotherapy. 57(6). 871–881. 23 indexed citations
14.
Karbach, Julia, et al.. (2007). Antibiotic resistance testing of the total implant-associated micro-flora and its pure isolates.. PubMed. 12(3). 120–8. 4 indexed citations
15.
Purbhoo, Marco A., Deborah H. Sutton, Joanna E. Brewer, et al.. (2006). Quantifying and Imaging NY-ESO-1/LAGE-1-Derived Epitopes on Tumor Cells Using High Affinity T Cell Receptors. The Journal of Immunology. 176(12). 7308–7316. 74 indexed citations
16.
Jäger, Elke, Julia Karbach, Sacha Gnjatic, et al.. (2002). Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51. PubMed. 2. 12–12. 28 indexed citations
17.
Jäger, Elke, Russell D. Salter, Chiara Castelli, et al.. (2002). Impact of Antigen Presentation on TCR Modulation and Cytokine Release: Implications for Detection and Sorting of Antigen-Specific CD8+ T Cells Using HLA-A2 Wild-Type or HLA-A2 Mutant Tetrameric Complexes. The Journal of Immunology. 168(6). 2766–2772. 6 indexed citations
18.
Karbach, Julia, Frank Momburg, Chiara Castelli, et al.. (1999). Cytotoxic T lymphocytes define multiple peptide isoforms derived from the melanoma-associated antigen MART-1/Melan-A. International Journal of Cancer. 81(6). 979–984. 11 indexed citations
19.
Jaeger, E., S Cayeux, Thomas Blankenstein, et al.. (1998). Strong Immunogenic Potential of a B7 Retroviral Expression Vector: Generation of HLA-B7-Restricted CTL Response Against Selectable Marker Genes. Human Gene Therapy. 9(1). 53–62. 21 indexed citations
20.
Jaeger, E., Helga Bernhard, Pedro Romero, et al.. (1996). Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptidesin vivo: Implications for tumor vaccines with melanoma-associated antigens. International Journal of Cancer. 66(2). 162–169. 195 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernard Lethé Breakdown of academic impact, for papers by Timothy M. Clay Breakdown of academic impact, for papers by Thorbald van Hall Breakdown of academic impact, for papers by Christophe Lurquin Breakdown of academic impact, for papers by Carlo Heirman Breakdown of academic impact, for papers by Roberto S. Accolla Breakdown of academic impact, for papers by Maria R. Parkhurst Breakdown of academic impact, for papers by Sebastian Kreiter Breakdown of academic impact, for papers by Jill E. Slansky Breakdown of academic impact, for papers by Amy Hobeika
Rankless by CCL
2026